Abstract: The present invention relates to a multi-component host material and an organic electroluminescent device comprising the same. By comprising a specific combination of the multi-component host compounds, the organic electroluminescent device according to the present invention can provide high luminous efficiency and excellent lifespan characteristics.

Abstract: The present invention relates to a method for producing a fibrosis-encapsulated tumoroid (FET), and the use of the fibrosis-encapsulated tumoroid. According to the present invention, an analogue that is close to real solid cancer tissue is produced using induced pluripotent stem cell-derived cell. The analogue has significant improvement over conventional tumoroids, which fail to perfectly reflect the characteristics of human solid cancer and have a very high probability of failure in the clinical validation stage. Thus, the present invention is expected to be widely used in the fields of new anticancer drug development and precision medicine.

Abstract: The present invention relates to a composition for increasing the bioavailability and promoting the absorption of ginsenosides in a black ginseng extract.

Abstract: The present invention relates to an anti-influenza virus composition, a composition for treating respiratory diseases, and an anti-aging composition, each of which comprises a dark ginseng extract.

Abstract: Disclosed is a pharmaceutical composition for preventing or treating cancer, containing streptonigrin and an mTOR inhibitor as active ingredients; and a composition for inhibiting angiogenesis, containing streptonigrin and a vascular endothelial growth factor (VEGF) inhibitor as active ingredients. Also disclosed is a cancer treatment method using streptonigrin and an mTOR inhibitor, a use in the preparation of anticancer drugs and a composition to be used in cancer prevention or treatment; and a method for inhibiting angiogenesis by using streptonigrin and a VEGF inhibitor, a use in the preparation of drugs for inhibiting angiogenesis and a composition to be used in angiogenesis inhibition. When a renal cancer cell line is treated with streptonigrin, which is a TGase2 inhibitor, in combination with rapamycin, which is an mTOR inhibitor, a cancer cell death effect can be exhibited to be greater than that when cancer cells are treated with each thereof, individually.

Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.

Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.

Abstract: Exemplary embodiments relate to a oral film including an anti-oxidative material having a high level of activity and a method for manufacturing the oral film for protecting the activity of an anti-oxidative material. The activity of the anti-oxidative material is retained under harsh conditions. An exemplary embodiment includes manufacturing a prolamin-based film for oral delivery. The method includes preparing a solution containing prolamin, glycerol formal, an anti-oxidative material, and a solvent including alcohol, and evaporating the solvent under a reduced pressure condition at a temperature of 0° C. to 80° C. An exemplary embodiment also includes a film for oral delivery, prepared by the preceding method, the film includes an anti-oxidative material that maintains activity at a high level.

Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.

Abstract: Disclosed herein is a. skin external composition containing ginseng berry extract. More specifically, disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract having the specific components and compositions, among the above-ground parts of ginseng, and thus promotes the production of collagen in the skin, shows an MMP-I inhibitory effect and, at the same time, has skin-aging inhibitory and wrinkle-reducing effects, resulting from antioxidant effects and DNA damage-protecting effects.

Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.

Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.

Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.

Abstract: Disclosed herein are a composition and a kit for diagnosing renal cell carcinoma. The composition and kit employ, as a renal cell carcinoma marker, nicotinamide N-methyltransferase, L-plastin, secretagogin, NM23A, CapG, which is an actin regulatory protein, and/or C4a anaphylatoxin.

Abstract: A composition containing ginseng berry extract as active ingredient is for facilitation of blood circulation, for prevention of vascular aging, for treatment of vascular inflammation, for facilitation of angiogenesis, for treatment of ischemic heart disease, for improvement and treatment of local blood circulation insufficiency, for improvement of skin beauty and for improvement of male sexual function.

Abstract: Disclosed herein are a composition and a kit for diagnosing renal cell carcinoma. The composition and kit employ, as a renal cell carcinoma marker, nicotinamide N-methyltransferase, L-plastin, secretagogin, NM23A, CapG, which is an actin regulatory protein, and/or C4a anaphylatoxin.

Abstract: Disclosed herein is a. skin external composition containing ginseng berry extract. More specifically, disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract having the specific components and compositions, among the above-ground parts of ginseng, and thus promotes the production of collagen in the skin, shows an MMP-I inhibitory effect and, at the same time, has skin-aging inhibitory and wrinkle-reducing effects, resulting from antioxidant effects and DNA damage-protecting effects.

Abstract: Disclosed herein is a composition for promoting AMPK activity, which comprises a chito-oligosaccharide as an active ingredient. The present composition affects the enzymes related to AMPK and lipid metabolism, and thus helps recovery from the condition lacking energy by various functions of controlling metabolism. Therefore, the present composition can enhance energy metabolism, thus making the composition effective for improving exercise capacity and reducing fatigue. The present composition can be used in the preparation of food or medicinal product as an endurance builder or for the prevention and improvement of fatigue.

Abstract: A user accesses the Internet, uses a chargeable service over the Internet and pays for use of the chargeable service. Accordingly, the present invention relates to a system providing information and billing for use of the information provided, using a medium storing therein an effective term and an authorization thereof at a pay site over the Internet, wherein use of the information can be billed and the billed amount is settled in an exact manner, without providing personal information of a client, as an information user. The billing system is characterized in that an authentication medium is bought in advance, and unique authentication information generated by entering hardware information specific to the user's computer is transmitted to a service gate and the user is allowed to log in the service gate, and payment for use of the information is transferred to a contents provider from the service gate.

Abstract: Disclosed is a method for certifying the identity of a user accessing the Internet and passing through a service gate over the Internet. In particular, the certification method uses a variable encryption key system based on encryption keys of a certification medium and inherent information of computer hardware. In the certification method, a certification medium is provided to the user, the certification medium is prepared by compilation of some pieces of encryption operation formula for certification into an execution file. When a user gains an access to the Internet for Internet use or certification, the remaining pieces of the certification formula are transmitted to the medium, thereby combining all the pieces of certification formula, forming a complete certification formula. Hardware information of the user computer is inputted thereinto, generating a unique value of encryption as certification information. The certification is completed when the certification is transmitted to the server.